Arcutis Biotherapeutics I...

NASDAQ: ARQT · Real-Time Price · USD
16.76
0.78 (4.88%)
At close: Aug 15, 2025, 3:05 PM

Arcutis Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-140.04M -262.14M -311.46M -206.36M
Depreciation & Amortization
2.6M 1.52M 934K 454K
Stock-Based Compensation
41.73M 38.81M 32.68M 23.89M
Other Working Capital
30.35M -3.68M 4.23M 3.38M
Other Non-Cash Items
-1.37M -1.75M 30.3M 309K
Deferred Income Tax
n/a n/a n/a 3.45M
Change in Working Capital
-15.08M -23.5M -10.18M 3.62M
Operating Cash Flow
-112.16M -247.06M -257.71M -174.63M
Capital Expenditures
-143K -428K -23.28M -995K
Cash Acquisitions
n/a n/a 22.95M 74.96M
Purchase of Investments
-254.82M -225.84M -415.39M -292.51M
Sales Maturities Of Investments
288.78M 406.5M 351.47M 217.55M
Other Investing Acitivies
-5M n/a -22.95M -74.96M
Investing Cash Flow
28.82M 180.23M -87.2M -75.95M
Debt Repayment
-100M n/a 125M 73.99M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.52M 2.42M 751K 470K
Financial Cash Flow
66.2M 101.32M 301.8M 281.95M
Net Cash Flow
-17.37M 34.45M -43.12M 31.37M
Free Cash Flow
-112.3M -247.49M -281M -175.62M